Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO · NASDAQ Global Market
-$0.05 today
Vol 1.08M · Avg 0.86M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+24.49%
Period High
$10.63
Period Low
$3.67
Latest
$4.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.29B
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$438.92M
DBV Technologies S.A.
NASDAQ:DBVT
$385.73M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$347.71M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$346.08M
Amarin Corporation plc
NASDAQ:AMRN
$334.13M
Silence Therapeutics plc
NASDAQ:SLN
$324.26M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$299.95M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.26M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.90M
What is the latest LXEO filing?
The latest filing shown is 8-K dated Jun 15, 2026.
How many recent filings does LXEO have?
Intrinsic Alpha currently shows 20 recent filings for LXEO.
Explore More
Continue the stock analysis
Jump to another research area for this company.